Genedrive PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genedrive PLC with three other
companies in this sector in the United Kingdom:
sales of £718,965.00 [US$922,935.37 ]
of which 100%
was Outsourced Systems and Computational Bio),
Fusion Antibodies PLC
(£2.18 million [US$2.80 million]
Avacta Group Plc
(£4.12 million [US$5.29 million]
Genedrive PLC reported sales of £2.36 million (US$3.03 million)
June of 2019.
increase of 21.9%
versus 2018, when the company's sales were £1.94 million.
Despite this increase, sales are still
below the level achieved in 2017, when Genedrive PLC
reported sales of £5.79 million.